← Back to Search

Behavioural Intervention

Cognitive Behavioral Therapy + Recovery Coaching for Opioid Use Disorder (OVERCOME 2 Trial)

N/A
Recruiting
Research Sponsored by Prisma Health-Upstate
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (≥18 years of age)
Currently receiving SL buprenorphine/ naloxone and/or buprenorphine HCL
Must not have
Have taken or received any prescribed buprenorphine product within 30 days prior to the current treatment episode.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 32 weeks
Awards & highlights

Summary

This trial will test if adding therapy & peer coaching to sublingual buprenorphine helps reduce illicit drug use. Outcomes will be compared in 3 arms: buprenorphine only, w/CBT4CBT, w/CBT4CBT & coaching. #DrugAbuse

Who is the study for?
Adults diagnosed with Opioid Use Disorder (OUD), currently on sublingual buprenorphine, and able to use a computer can join. They must be willing to be randomly assigned to a treatment group and have started buprenorphine within the last 30 days. Those with severe health or mental issues, pregnant or breastfeeding women, non-English speakers/readers, or those who've used prescribed buprenorphine in the past month cannot participate.
What is being tested?
The trial tests if adding computer-based cognitive behavioral therapy (CBT4CBT) alone or combined with peer recovery coaching improves outcomes for those on standard opioid addiction treatment with sublingual buprenorphine. It measures drug use reduction over an 8-week period and checks how well patients stick to their treatments up to six months later.
What are the potential side effects?
While this study primarily involves therapy interventions which typically do not have physical side effects like medications do, participants may experience emotional discomfort discussing substance use history during CBT sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am currently taking SL buprenorphine/naloxone or buprenorphine HCL.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have used a prescribed buprenorphine product in the last 30 days.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~32 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 32 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Buprenorphine retention at 3-month follow-up
Buprenorphine retention at 6-month follow-up
Drug use
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Standard of care + CBT4CBT+ RCExperimental Treatment2 Interventions
This condition will integrate the standard of care, CBT4CBT, and recovery coaching services with Assertive Community Engagement (ACE) model interventions. The CBT4CBT is an 8-session (module) system for teaching with one module on the basics of buprenorphine and the other modules on the seven CBT core skills tailored around issues related to buprenorphine and OUD and other SUDs Peer recovery coaching services involve a form of nonclinical, peer support aimed at helping individuals with substance use disorders to achieve and maintain recovery. Recovery coaches are individuals with experience with substance use and successful recovery. In addition to their lived experience, recovery coaches obtain formal training on substance use coaching and receive ongoing supervision. The recovery coaches use an assertive engagement approach to provide holistic, person-centered, and strength-based support.
Group II: Standard of care + CBT4CBTExperimental Treatment1 Intervention
This condition will integrate the standard of care and CBT4CBT interventions. The CBT4CBT is an 8-session (module) system for teaching with one module on the basics of buprenorphine and the other modules on the seven CBT core skills tailored around issues related to buprenorphine and OUD and other SUDs: (1) Introduction to functional analysis of substance use; (2) strategies for recognizing and coping with craving; (3) refusal skills and assertiveness; (4) training in problem-solving skills; (5) strategies for recognizing and changing thoughts; (6) decision-making skills; (7) how to use CBT skills to reduce HIV/ HCV risk. Each module takes 30 minutes to complete and has a format, which includes on-screen narration, animation, quizzes, and interactive exercises to teach and model effective use of skills. Modules end with a practice exercise.
Group III: Standard of careActive Control1 Intervention
Participants in the standard of care condition will receive the standard treatment at the recovery program, which consists of weekly, bi-weekly or monthly visits (at the discretion of the provider) in-person or virtually. This condition will be matched with the other conditions in terms of the number of research visits.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CBT4CBT
2017
Completed Phase 4
~430

Find a Location

Who is running the clinical trial?

Prisma Health-UpstateLead Sponsor
84 Previous Clinical Trials
43,624 Total Patients Enrolled
Clemson UniversityOTHER
35 Previous Clinical Trials
6,579 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,543 Previous Clinical Trials
3,249,286 Total Patients Enrolled
~28 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top